...
首页> 外文期刊>Brain research >Cocaine self-administration and locomotor activity are altered in Lewis and F344 inbred rats by RTI 336, a 3-phenyltropane analog that binds to the dopamine transporter.
【24h】

Cocaine self-administration and locomotor activity are altered in Lewis and F344 inbred rats by RTI 336, a 3-phenyltropane analog that binds to the dopamine transporter.

机译:可卡因的自我给药和运动活性通过RTI 336(一种与多巴胺转运蛋白结合的3-苯基环烷类似物)在Lewis和F344近交大鼠中发生了改变。

获取原文
获取原文并翻译 | 示例

摘要

Lewis and Fischer 344 (F344) rats differ in responses to cocaine and characteristics of the mesolimbic dopamine system. Compared to F344 rats, Lewis rats have lower D2 receptor and dopamine transporter (DAT) levels in nucleus accumbens (NAc). We showed previously that altering D1 and D2 receptor levels pharmacologically had strain-dependent effects on cocaine self-administration. This study tests whether the phenyltropane analog, 3beta-(4-Chlorophenyl) tropane-2beta-[3-(4'-methylphenyl) isoxazol-5-yl] Hydrochloride (RTI 336), a potent and selective DAT inhibitor, differentially alters reinforcing, discriminative, and locomotor effects of cocaine in these strains. The effects of RTI 336 pretreatment on cocaine self-administration were assessed under a fixed-ratio (FR) schedule of reinforcement. Its effects on cocaine discrimination were conducted using a two-lever food-reinforced task. Finally, the effects of RTI 336 pretreatment on cocaine-induced locomotor activity were examined. RTI 336 increased cocaine self-administration in F344 rats, while Lewis rats showed reduced intake under the FR schedule. RTI 336 reduced cocaine-induced locomotor activity in Lewis rats but not in F344 rats. RTI 336 did not substitute for or antagonize cocaine's discriminative stimulus effects in either strain. Results show that a DAT inhibitor alters cocaine-induced behaviors in a strain-dependent manner. These effects may relate to inherent differences in NAc DAT levels between Lewis and F344 rats.
机译:Lewis和Fischer 344(F344)大鼠对可卡因的反应和中脑边缘多巴胺系统的特征不同。与F344大鼠相比,Lewis大鼠伏隔核(NAc)中的D2受体和多巴胺转运蛋白(DAT)水平较低。我们以前表明药理学改变D1和D2受体水平对可卡因的自我给药具有菌株依赖性作用。这项研究测试了一种有效的,选择性的DAT抑制剂苯基托烷类似物3beta-(4-氯苯基)tropane-2beta- [3-(4'-甲基苯基)异恶唑-5-基]盐酸盐(RTI 336)是否能不同地改变增强作用可卡因在这些菌株中的作用,区别和运动作用。 RTI 336预处理对可卡因自我给药的作用在固定比例(FR)强化方案下进行评估。它对可卡因歧视的影响是通过两杆食物强化任务进行的。最后,检查了RTI 336预处理对可卡因诱导的运动活性的影响。 RTI 336增加了F344大鼠的可卡因自我给药,而Lewis大鼠在FR方案下显示摄入减少。 RTI 336降低了可卡因诱导的Lewis大鼠运动能力,但未降低F344大鼠的运动能力。 RTI 336不能替代或拮抗可卡因在两种菌株中的歧视性刺激作用。结果表明,DAT抑制剂以应变依赖性方式改变可卡因诱导的行为。这些影响可能与Lewis和F344大鼠之间NAc DAT水平的固有差异有关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号